Cargando…
Anti-tumor Efficacy of CD19 CAR-T in a Raji B Cell Xenografted Mouse Model
Chimeric antigen receptor (CAR)-T therapy launched a new era for cancer treatments, displaying outstanding effectiveness in relapsed or refractory B-cell malignancies. Demonstrating the tumor-killing ability of CAR-Ts in mouse xenograft models serves as a golden criterium in preclinical research. He...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bio-Protocol
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10127058/ https://www.ncbi.nlm.nih.gov/pubmed/37113332 http://dx.doi.org/10.21769/BioProtoc.4655 |